Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
Blood cancer discovery
Saved in:
Main Authors: | Davies, FE, Pawlyn, C, Usmani, SZ, San-Miguel, JF, Einsele, H, Boyle, EM, Corre, J, Auclair, D, Cho, HJ, Lonial, S, Sonneveld, P, Stewart, AK, Bergsagel, PL, Kaiser, MF, Weisel, K, Keats, JJ, Mikhael, JR, Morgan, KE, Ghobrial, IM, Orlowski, RZ, Landgren, CO, Gay, F, Caers, J, Chng, WJ, Chari, A, Walker, BA, Kumar, SK, Costa, LJ, Anderson, KC, Morgan, GJ |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
American Association for Cancer Research (AACR)
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/237779 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
by: Davies, FE, et al.
Published: (2023) -
Management of treatment-emergent peripheral neuropathy in multiple myeloma
by: Richardson, P.G., et al.
Published: (2016) -
Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
by: Chng, W.-J., et al.
Published: (2014) -
The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network
by: Tan, D., et al.
Published: (2016) -
Natural history and prognostic factors at first relapse in multiple myeloma
by: Wang, C., et al.
Published: (2021)